Nuvation Bio Inc. (NUVB) Insider Ownership

Historic Insider Ownership Trends

As of April 17, 2026, the three largest insider holders of NUVB are David Hung (President And Ceo, 59.28Mn shares), Xiangmin Cui (Director, 25.95Mn shares), Fund V, L.P. Omega (TenPercentOwner, 20.46Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
David Hung President And Ceo 59,281,054 0 18 Jun, 2025
Xiangmin Cui - 0 25,954,439 05 Sep, 2024
Fund V, L.P. Omega - 20,457,340 0 07 Apr, 2022
Fund V, L.P. Omega - 20,457,340 0 07 Apr, 2022
Oleg Nodelman - 0 12,674,775 22 Sep, 2023
Junyuan Jerry Wang Ceo, Anheart Therapeutics Ltd. 3,866,228 0 13 Nov, 2024
Junyuan Jerry Wang Ceo, Anheart Therapeutics Ltd. 3,866,228 0 13 Nov, 2024
Junyuan Jerry Wang Ceo, Anheart Therapeutics Ltd. 0 2,246,458 05 Sep, 2024
Junyuan Jerry Wang Ceo, Anheart Therapeutics Ltd. 0 2,246,458 05 Sep, 2024
Daniel G Welch - 659,947 0 29 May, 2024
Daniel G Welch - 659,947 0 29 May, 2024
Kathryn E Falberg - 0 250,000 05 Dec, 2022
Robert Mashal - 0 200,000 03 Apr, 2025
Kim D Blickenstaff - 0 172,189 13 Jun, 2024
Colleen Sjogren Chief Commercial Officer 81,000 0 18 Jun, 2025
Colleen Sjogren Chief Commercial Officer 81,000 0 18 Jun, 2025
Moses Makunje - 68,137 0 03 Mar, 2026
Kerry Wentworth Chief Regulatory Officer 53,000 0 08 Apr, 2026
Stacy Markel Chief People Officer 29,591 0 18 Jun, 2025
David C. Hanley Chief Technical Operations 24,000 0 21 Nov, 2025
Dongfang Liu Chief Medical Officer 18,000 0 03 Dec, 2025
Philippe Sauvage Chief Financial Officer 9,902 0 18 Jun, 2025
Philippe Sauvage Chief Financial Officer 9,902 0 18 Jun, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
06 Apr, 2026 Kerry Wentworth Class A Common Stock A 100,000 $1.87 153,000 D M
06 Apr, 2026 Kerry Wentworth Class A Common Stock A 100,000 $1.94 253,000 D M
06 Apr, 2026 Kerry Wentworth Class A Common Stock D 200,000 $4.52 53,000 D S
06 Apr, 2026 Kerry Wentworth Stock Option (Right to Buy) D 100,000 $0.00 400,000 D M
06 Apr, 2026 Kerry Wentworth Stock Option (Right to Buy) D 100,000 $0.00 300,000 D M
27 Feb, 2026 Xiangmin Cui Stock Option (Right to Buy) A 74,813 $0.00 74,813 D A
27 Feb, 2026 David Hung Stock Option (Right to Buy) A 1,995,012 $0.00 1,995,012 D A
27 Feb, 2026 Gary Hattersley Stock Option (Right to Buy) A 748,130 $0.00 748,130 D A
27 Feb, 2026 Moses Makunje Class A Common Stock A 50,761 $0.00 68,137 D A
27 Feb, 2026 David C. Hanley Stock Option (Right to Buy) A 748,130 $0.00 748,130 D A
27 Feb, 2026 Dongfang Liu Stock Option (Right to Buy) A 748,130 $0.00 748,130 D A
27 Feb, 2026 Colleen Sjogren Stock Option (Right to Buy) A 748,130 $0.00 748,130 D A
27 Feb, 2026 Moses Makunje Stock Option (Right to Buy) A 224,439 $0.00 224,439 D A
27 Feb, 2026 Kerry Wentworth Stock Option (Right to Buy) A 748,130 $0.00 748,130 D A
27 Feb, 2026 Philippe Sauvage Stock Option (Right to Buy) A 748,130 $0.00 748,130 D A
27 Feb, 2026 Stacy Markel Stock Option (Right to Buy) A 748,130 $0.00 748,130 D A
01 Dec, 2025 Dongfang Liu Class A Common Stock A 150,000 $2.93 168,000 D M
01 Dec, 2025 Dongfang Liu Class A Common Stock D 150,000 $7.82 18,000 D S
01 Dec, 2025 Dongfang Liu Stock Option (Right to Buy) D 150,000 $0.00 165,000 D M
25 Nov, 2025 Dongfang Liu Class A Common Stock A 10,000 $3.61 28,000 D M